Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimens.
Martinetti A, Miceli R, Sottotetti E, Di Bartolomeo M, de Braud F, Gevorgyan A, Dotti KF, Bajetta E, Campiglio M, Bianchi F, Bregni G, Pietrantonio F.
Martinetti A, et al. Among authors: bregni g.
Cancers (Basel). 2014 Aug 29;6(3):1753-68. doi: 10.3390/cancers6031753.
Cancers (Basel). 2014.
PMID: 25256831
Free PMC article.